| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |